HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study.

AbstractAIMS:
The control of blood glucose levels, blood pressure (BP), and low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of diabetes complications; however, data are scarce on control status of these factors among workers with diabetes. The present study aimed to estimate the prevalence of participants with diabetes who meet glycated hemoglobin (HbA1c), BP, and LDL-C recommendations, and to investigate correlates of poor glycemic control in a large working population in Japan.
METHODS:
The Japan Epidemiology Collaboration on Occupational Health (J-ECOH) Study is an ongoing cohort investigation, consisting mainly of employees in large manufacturing companies. We conducted a cross-sectional analysis of 3,070 employees with diabetes (2,854 men and 216 women) aged 20-69 years who attended periodic health examinations. BP was measured and recorded using different company protocols. Risk factor targets were defined using both American Diabetes Association (ADA) guidelines (HbA1c < 7.0%, BP < 140/90 mmHg, and LDL-C < 100 mg/dL) and Japan Diabetes Society (JDS) guidelines (HbA1c < 7.0%, BP < 130/80 mmHg, and LDL-C < 120 mg/dL). Logistic regression models were used to explore correlates of poor glycemic control (defined as HbA1c ≥ 8.0%).
RESULTS:
The percentages of participants who met ADA (and JDS) targets were 44.9% (44.9%) for HbA1c, 76.6% (36.3%) for BP, 27.1% (56.2%) for LDL-C, and 11.2% (10.8%) for simultaneous control of all three risk factors. Younger age, obesity, smoking, and uncontrolled dyslipidemia were associated with poor glycemic control. The adjusted odds ratio of poor glycemic control was 0.58 (95% confidence interval, 0.46-0.73) for participants with treated but uncontrolled hypertension, and 0.47 (0.33-0.66) for participants with treated and controlled hypertension, as compared with participants without hypertension. There was no significant difference in HbA1c levels between participants with treated but uncontrolled hypertension and those with treated and controlled hypertension.
CONCLUSION:
Data from a large working population, predominantly composed of men, suggest that achievement of HbA1c, BP, and LDL-C targets was less than optimal, especially in younger participants. Uncontrolled dyslipidemia was associated with poor glycemic control. Participants not receiving antihypertensive treatment had higher HbA1c levels.
AuthorsHuanhuan Hu, Ai Hori, Chihiro Nishiura, Naoko Sasaki, Hiroko Okazaki, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Kentaro Tomita, Toshiaki Miyamoto, Satsue Nagahama, Akihiko Uehara, Makoto Yamamoto, Taizo Murakami, Chii Shimizu, Makiko Shimizu, Masafumi Eguchi, Takeshi Kochi, Teppei Imai, Akiko Okino, Keisuke Kuwahara, Ikuko Kashino, Shamima Akter, Kayo Kurotani, Akiko Nanri, Isamu Kabe, Tetsuya Mizoue, Naoki Kunugita, Seitaro Dohi, Japan Epidemiology Collaboration on Occupational Health Study Group
JournalPloS one (PLoS One) Vol. 11 Issue 7 Pg. e0159071 ( 2016) ISSN: 1932-6203 [Electronic] United States
PMID27437997 (Publication Type: Journal Article)
Chemical References
  • Antihypertensive Agents
  • Glycated Hemoglobin A
  • Hypolipidemic Agents
  • Lipids
Topics
  • Adult
  • Aged
  • Antihypertensive Agents (pharmacology, therapeutic use)
  • Blood Pressure (drug effects)
  • Cooperative Behavior
  • Diabetes Mellitus (blood, epidemiology, physiopathology)
  • Female
  • Glycated Hemoglobin (analysis)
  • Humans
  • Hypolipidemic Agents (pharmacology, therapeutic use)
  • Japan (epidemiology)
  • Lipids (blood)
  • Male
  • Middle Aged
  • Occupational Health
  • Prevalence
  • Risk Factors
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: